Cargando…
163例弥漫大B细胞淋巴瘤患者预后相关免疫表型研究
OBJECTIVE: To screen and analyze the prognostic protein biomarkers of DLBCL, and to explore their value in the prognostic evaluation. METHODS: 163 cases of confirmed DLBCLs from January 2011 to December 2016 were collected with their clinical, pathological and follow-up data, which were all from our...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295611/ https://www.ncbi.nlm.nih.gov/pubmed/34384155 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.06.008 |
Ejemplares similares
-
弥漫大B细胞淋巴瘤患者蛋白表达检测的预后意义
Publicado: (2017) -
166例双表达弥漫大B细胞淋巴瘤临床特征与预后分析
Publicado: (2022) -
肿瘤相关巨噬细胞对弥漫大B细胞淋巴瘤预后影响机制的研究进展
Publicado: (2018) -
63例HIV相关弥漫大B细胞淋巴瘤临床特征及预后分析:国内单中心真实世界研究
Publicado: (2022) -
LymphGen基因分型在弥漫大B细胞淋巴瘤患者中的分布特征及预后价值验证
Publicado: (2022)